Abstract submission is now closed.

Abstract topics

  • Dementia Diagnosis
  • New and Future Treatments
  • Dementia Prevention and Risk Factors
  • Non-pharmacological Interventions
  • Quality of Life
  • Person Centred Care
  • Support and Training for Informal and Professional Carers
  • Educating and Training of Medical Professionals

Important Dates

Submission deadline: 10 August 2012, Midnight GMT

Notifications to submitters: 21 September 2012

Abstracts received after the deadline will not be accepted.


Failure to observe these rules may result in disqualification.

1. Abstracts can only be submitted via the online abstract submission form that can be found on this website (www.adicairo2012.org)

2. Abstracts must be submitted in English.

3. Abstracts sent by post or email will not be accepted.

4. The correct topic must be selected to ensure correct scoring. The content of the abstract must be related to the topic.

5. Abstracts must contain data and meet international ethical standards.

6. Abbreviations should be defined.

7. Trade names must not be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.

8. If any of the authors has a conflict of interest, this must be clearly stated.

9. The abstract cannot be more than 300 words. This and any other length limits are as counted by the online form.

10. The abstract should be structured with four sections as follows:

  • Objectives
  • Methods
  • Results
  • Conclusion

11. If you have successfully submitted your abstract, you will be emailed a submission number. If you do not receive an email confirmation, the abstract cannot be considered as successfully submitted.

12. You may edit your abstract after submission. The version of the abstract at the time of the abstract deadline is the one that will be considered.

13. Please ensure that your abstract does not contain spelling, grammatical or scientific errors. The abstract will be reproduced as submitted. No proofreading will be done.

14. If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be submitted no later than 21 October 2012.


Submitting author: person who physically submits the abstract. Presenting author: person who will physically present the abstract at the conference and who is marked as the presenter in the programme. First author: First author cited who scientifically endorses the abstract and is therefore responsible for its content

After submission

The reviewers will judge the abstracts according to the relevance to the ADI Middle East 2012 conference, standard of English, objectivity of statements, description of what was done, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall impression.

The submitting authors will be notified by 21 September 2012, at the email address provided during submission, as to whether their abstract has been accepted. It is the author's responsibility to ensure that emails from ADI can reach them. They will be informed at the same time about the date, time and form of their presentation. Presentation guidelines will be included in the acceptance letter.

Publication policy

All abstracts accepted for presentation (oral or poster) may be published with the official abstracts of the conference, in print or online.

Problems submitting?

If you experience any problems or have any questions, please contact Jane Cziborra on +44 20 7981 0880.

Submission form

Abstract submission is now closed.